Author Question: A particle (mass = 6.7 10-27 kg, charge = 3.2 10-19 C) moves along the positive x axis with a ... (Read 1598 times)

storky111

  • Hero Member
  • *****
  • Posts: 561
A particle (mass = 6.7  10-27 kg, charge = 3.2  10-19 C) moves along the positive x axis with a speed of 4.8  105 m/s. It enters a region of uniform electric field parallel to its motion and comes to rest after moving 2.0 m into the field. What is the magnitude of the electric field?
 a. 2.0 kN/C
  b. 1.5 kN/C
  c. 1.2 kN/C
  d. 3.5 kN/C
  e. 2.4 kN/C

Question 2

A particle (charge = +2.0 mC) moving in a region where only electric forces act on it has a kinetic energy of 5.0 J at point A. The particle subsequently passes through point B which has an electric potential of +1.5 kV relative to point A. Determine the kinetic energy of the particle as it moves through point B.
 a. 3.0 J
  b. 2.0 J
  c. 5.0 J
  d. 8.0 J
  e. 10.0 J



dmurph1496

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

C

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

storky111

  • Hero Member
  • *****
  • Posts: 561
Both answers were spot on, thank you once again



dmurph1496

  • Sr. Member
  • ****
  • Posts: 343

 

Did you know?

About 600,000 particles of skin are shed every hour by each human. If you live to age 70 years, you have shed 105 pounds of dead skin.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library